AKIN GUMP STRAUSS HAUER & FELD

Lobbying for GENENTECH INC · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Issues related to public health preparedness; issues related to access to medicines for minority communities; issues related to healthcare education and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.